autologous dendritic cell vaccine

BIOLOGICAL6 trials

Conditions

Adjuvant Drug TherapyCutaneous T-cell LymphomaEBV Associated Lymphoid NeoplasmsMalignant MelanomaMelanomaMelanoma Stage III or IVNeoplasms, Connective and Soft TissueSarcoma

Phase 1

Peptide-pulsed vs. RNA-transfected Dendritic Cell Vaccines in Melanoma Patients

CompletedNCT00243529

Radboud University Medical CenterMelanoma Stage III or IV

Start: 2004-04-30Updated: 2009-09-29

Single-step Antigen Loading and TLR Activation of Dendritic Cells in Melanoma Patients

CompletedNCT01530698

Radboud University Medical CenterMelanoma

Start: 2010-04-30End: 2014-11-30Updated: 2017-04-17

Autologous Dendritic Cell Vaccine in Patients With Soft Tissue Sarcoma

NCT01883518

N.N. Petrov National Medical Research Center of OncologyNeoplasms, Connective and Soft Tissue, Sarcoma

Start: 2013-06-30End: 2020-09-30Target: 48Updated: 2019-11-20

Phase 2

Immunization Against Tumor Cells in Sezary Syndrome

CompletedNCT00099593

University of PittsburghCutaneous T-cell Lymphoma, Sezary Syndrome

Start: 2004-09-30End: 2007-09-30Target: 17Updated: 2015-03-25

Complementary Vaccination With Dendritic Cells Pulsed With Autologous Tumor Lysate in Resected Stage III and IV Melanoma Patients.

TerminatedNCT02718391

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSAdjuvant Drug Therapy, Malignant Melanoma, Vaccin Therapy

Start: 2015-08-31End: 2019-11-30Updated: 2020-04-22

Unknown Phase

KSD-101 in Patients With EBV-associated Hematological Malignancies

Not yet recruitingNCT07525024

Ruijin HospitalEBV Associated Lymphoid Neoplasms

Start: 2026-04-01End: 2031-03-01Target: 80Updated: 2026-04-13

Related Papers

Adjuvant dendritic cell-based immunotherapy in melanoma: insights into immune cell dynamics and clinical evidence from a phase II trial

Journal of Translational Medicine2025-04-183 citations

iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy.